A20-hCD22

Export PDF

Strain Information

Cell Line

A20-Cd22em1(hCD22)Smoc

Cat. NO.

NMC-230006

Model Description

CD22 gene humanized A20 B cell line

Strain State

Validation of tumorigenic capacity completed

Validation Data

1. CD22 expression on in vitro cultured cells of A20-hCD22 cell line

1-1.png

2. In vivo validation of A20-hCD22 in BALB/c mice

1-2.png

3. CD22 expression in tumors after in vivo growth of A20-hCD22 in wild type BALB/c mice

1-3.png


Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more